Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The new 7,000-square-meter plant is located in France and will begin production of thorium-228, necessary for the development of isotopes used in cancer treatments.
One of the largest radiopharma companies in the world is acquiring global rights to a pair of novel therapeutic and diagnostic drugs used to target a peptide receptor overexpressed in prostate and breast cancers.
"This article will serve as a landmark reference for navigating short-term labor challenges in radiology," explains one editorial about the suggestions.
In an initial comparison study involving 10 patients with high-risk prostate cancer, ultrasound tomography (UT) soundly beat 7-Tesla multiparametric MRI on detection sensitivity, 85.7% to 65.3%.
Bob Still, executive director of the Radiologist Business Management Association, believes CMS’s proposed physician fee schedule for 2023 will harm vulnerable populations and seriously injure U.S. healthcare. Hear him out.
SHELTON, Conn., July 26, 2022 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will install its enterprise imaging system at Cooper University Health Care.
Point-of-care ultrasound innovator Exo has acquired Medo AI of Edmonton, Alberta, with plans to soon make ultrasound imaging “as easy as snapping a photo on a smartphone.”
Radiology researchers from six leading medical schools have laid out some attuned and readily adoptable strategies for groups challenged to prosper in a time of difficult reimbursement dynamics.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.